Rapid exacerbation of neuromyelitis optica after rituximab treatment

Journal of Clinical Neuroscience

Volumn 26, Issue , 2016, Pages 168-170

  Dai, Yongqiang ^a   Lu, Tingting ^a   Wang, Yuge ^a   Fang, Ling ^a   Li, Rui ^a   Kermode, Allan G ^b,c   Qiu, Wei ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

Neuromyelitis optica; Relapse; Rituximab; Therapy

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; TOCILIZUMAB; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; HICCUP; HUMAN; IMAGE ANALYSIS; LIMB WEAKNESS; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARAPLEGIA; PLASMAPHERESIS; PRIORITY JOURNAL; SPINAL CORD LESION; TREATMENT RESPONSE; WHITE MATTER LESION; NEUROMYELITIS OPTICA; RECURRENT DISEASE;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEUROMYELITIS OPTICA; RECURRENCE; RITUXIMAB;

EID: 84950244145     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2015.08.033     Document Type: Article

References (11)

1. W. Qiu, A.G. Kermode, R. Li, and et al. Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica J Clin Neurosci 22 2015 1178 1182
2. M.A. Mealy, D.M. Wingerchuk, J. Palace, and et al. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy JAMA Neurol 71 2014 324 330
3. J.S. Perumal, I. Kister, J. Howard, and et al. Disease exacerbation after rituximab induction in neuromyelitis optica Neurol Neuroimmunol Neuroinflamm 2 2015 e61
4. M. Capobianco, S. Malucchi, A. di Sapio, and et al. Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease) Neurol Sci 28 2007 209 211
5. A. Jacob, B.G. Weinshenker, I. Violich, and et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients Arch Neurol 65 2008 1443 1448
6. S.H. Kim, S.Y. Huh, S.J. Lee, and et al. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder JAMA Neurol 70 2013 1110 1117
7. D.M. Wingerchuk, B. Banwell, J.L. Bennett, and et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Neurology 85 2015 177 189
8. V. Patel, N.C. Griffith, E. Blackwood, and et al. Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy J Clin Neurosci 19 2012 1576 1578
9. A. McKeon, and S. Pittock Individualized rituximab treatment for neuromyelitis Optica spectrum disorders JAMA Neurol 70 2013 1103 1104
10. H.H. Wang, Y.Q. Dai, W. Qiu, and et al. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse J Clin Neurosci 18 2011 1313 1317
11. I. Ayzenberg, I. Kleiter, A. Schroder, and et al. Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy JAMA Neurol 70 2013 394 397